Abstract:Evolutionary path of cancer therapeutics which started around eighty-two years ago, following serendipitous discovery of nitrogen mustard [1] has been guided by an accelerated pace of new discoveries, an ever-increasing depth of understanding of intracellular biological processes [2] and application of advances made in other fields of science [3]. Success in any field, especially in cancer medicine, is based on embracing evolution in understanding other scientific fields [4] and its application to the forward move in cancer therapeutics. As such, we have gone through discovery of a diverse group of therapeutics, targeting different sub compartments of growth and proliferation pathways [5] and taking advantage of their synergistic efficacy, in different combinations [6]. Dissection of immune regulatory pathways [7] and their interaction with cancer cell has led to the generation of modern immune therapeutic agents. Single-cell sequencing technology [8] has paved the way for the development of spatial omics [9], which has opened the way on deeper understanding of tumor evolutionary path [10]. This would give us the opportunity to design a new generation of cancer therapeutics [11] intercepting with the forward evolutionary path of tumor mass. Along this path, we face insurmountable barriers in developing meaningful and game changing treatment strategies by directing single changes in a hyper complex biological system [12], manifested by complexities of genome [13], epigenome [14], microRNA network [15], gene regulatory mechanisms [16], and protein-protein interactions [17]. Consequently, we need to search for a solution that enables us to freeze or slow down the forward evolutionary path of tumor mass [18], by making a single change in a game changing variable of cancer cell.

Early Cancer Detection Through Comprehensive Mapping of Dynamic Tumorigenesis

Tumor Diversity and Evolution Revealed Through RADseq

Emerging strategies to investigate the biology of early cancer

Medical imaging in tumor precision medicine: opportunities and challenges

Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer

High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis

Identification, Modeling and Simulation of Key Pathways Underlying Certain Cancers

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Resolving tumor evolution: a phylogenetic approach

Prostate Cancer Progression Modeling Provides Insight into Dynamic Molecular Changes Associated with Progressive Disease States

Spatial omics: Navigating to the golden era of cancer research

The Cancer Genome Anatomy Project: EST sequencing and the genetics of cancer progression

Early and multiple origins of metastatic lineages within primary tumors

Timing somatic events in the evolution of cancer

CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model

Joint analysis of mutational and transcriptional landscapes in human cancer reveals key perturbations during cancer evolution

Digital oncology, the dawn of a new era turning the clock back on tumor mass

Characterizing the Ecological and Evolutionary Dynamics of Cancer

From microscopes to molecules: The evolution of prostate cancer diagnostics

Approaches to Uncovering Cancer Diagnostic and Prognostic Molecular Signatures.

Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks